HIV Infection: Ten key management points for primary care physicians;Infection VIH: Dix points clés pour la prise en charge par les praticiens

Medecine et Hygiene

Volumn 62, Issue 2479, 2004, Pages 862-868

  Khonkarly, Mona B ^a   Merlani, Giorgio M ^a   Halfon, Patricia ^a,b   Bellini, Cristina ^a   Pelet, Anne ^a,c   Kazadi, Kayole ^a   Cavassini, Matthias L ^a   Tarr, Philip E ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c Centre Saint Martin   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PEGINTERFERON; RIBAVIRIN;

COUNSELING; CYTOPENIA; DEPRESSION; DISEASE TRANSMISSION; GENERAL PRACTITIONER; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; NONHUMAN; PATIENT COMPLIANCE; PREGNANCY; PRIMARY INFECTION; PRIMARY MEDICAL CARE; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 2142752482     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Sida et VIH en Suisse: situation épidémiologique à fin 2002. Office fédéral de la santé publique. www.admin.ch/bag/infekt/surv/aids/f/index.htm
2. Royce RA, Sena A, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997; 336: 1072-8.
3. Nonoccupational HIV PEP task force of the Brown University AIDS Program (BRUNAP) and the Rhode Island Department of Health (HEALTH). Nonoccupational Human Immunodeficiency Postexposure Prophylaxis Guidelines for Rhode Island Healthcare Practicioners. www.brown.edu/Department/BRUNAP/backnpep.htm
4. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1 discordant coupies in Rakai, Uganda. Lancet 2001; 357: 1149-53.
5. Kasten MJ. Human Immunodeficiency Virus: The initial physician-patient encounter. Mayo Clin Proc 2002; 77: 957-63.
6. Freedberg KA, Samet JH. Think HIV: Why physicians should lower their threshold for HIV testing. Arch Intern Med 1999; 159: 1994-2000.
7. The Antiretroviral Therapy Cohort Collaboration. Prognostic importance of initial response in HIV-1 infected patients starting otent antiretroviral therapy: Analysis of prospective studies. Lancet 2003; 362: 679-86.
8. Furrer H. Traitement et prévention des infections opportunistes les plus importantes associées au virus HIV. Forum Med Suisse 2001; 23: 605-12.
9. www.HIV-druginteractions.org. Un de plusieurs sites web spécialisés dans les interactions médicamenteuses des traitements antirétroviraux (développé et maintenu par la Liverpool HIV Pharmacology Group)
10. 2002 USPHS/IDSA Guidelines for Preventing Opportunistic Infections among HIV-infected Persons: http://www.cdc.gov/mmwr/preview/mm wrhtml/rr508a1.htm
11. Shelbume III SA, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome. Emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002; 81: 213-27.
12. Mofenson LM, Centers for Disease Control and Prevention, USPHST. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant VIH-1-infected women for maternal health and interventions to reduce perinatal VIH-1 transmission in the United States (revised September 22, 2003): http://www.aidsinfo. nih.gov/guidelines/perinatal/PER_1 12603.pdf
13. www.hivandhepatitis.com Un site web de qualité où l'on trouvera beaucoup d'informations utiles et des liens avec d'autres sites.
14. re édition, Genève: Editions Médecine et Hygiène, 2003.